|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 160.60 EUR | -1.29% |
|
+4.76% | +35.30% |
| 06-23 | THX Pharma appoints Sophie Jacq Lapointe to its board of directors | |
| 06-12 | Could This Finally Be the One? |
Company Valuation: Ipsen
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 6,621 | 8,279 | 8,912 | 9,155 | 9,770 | 13,333 | - | - |
| Change | - | 25.05% | 7.65% | 2.72% | 6.72% | 36.47% | - | - |
| Enterprise Value (EV) 1 | 6,758 | 7,894 | 8,860 | 9,020 | 9,225 | 11,971 | 10,961 | 10,181 |
| Change | - | 16.81% | 12.22% | 1.81% | 2.28% | 29.76% | -8.44% | -7.12% |
| P/E | 10.4x | 12.9x | 14x | 26.7x | 22.4x | 15x | 14.7x | 14.6x |
| PBR | 2.42x | - | 2.36x | 2.22x | 2.3x | 2.67x | 2.2x | 1.9x |
| PEG | - | 20.02x | -13.67x | -0.6x | 0.8x | 0x | 5.98x | 23.02x |
| Capitalization / Revenue | 2.31x | 2.74x | 2.85x | 2.69x | 2.49x | 3.13x | 2.98x | 2.86x |
| EV / Revenue | 2.36x | 2.61x | 2.83x | 2.65x | 2.35x | 2.81x | 2.45x | 2.19x |
| EV / EBITDA | 5.8x | 5.86x | 10.1x | 7.52x | 6.67x | 7.23x | 6.5x | 6.12x |
| EV / EBIT | 6.68x | 7.08x | 8.85x | 8.13x | 7.13x | 8.45x | 7.52x | 6.97x |
| EV / FCF | 8.31x | 9.02x | 12.5x | 11.6x | 8.93x | 11.1x | 9.58x | 8.73x |
| FCF Yield | 12% | 11.1% | 8.02% | 8.59% | 11.2% | 9.04% | 10.4% | 11.5% |
| Dividend per Share 2 | 1.2 | 1.2 | 1.2 | 1.4 | 1.4 | 1.431 | 1.484 | 1.582 |
| Rate of return | 1.49% | 1.19% | 1.11% | 1.26% | 1.18% | 0.88% | 0.91% | 0.97% |
| EPS 2 | 7.76 | 7.81 | 7.73 | 4.15 | 5.32 | 10.81 | 11.07 | 11.15 |
| Distribution rate | 15.5% | 15.4% | 15.5% | 33.7% | 26.3% | 13.2% | 13.4% | 14.2% |
| Net sales 1 | 2,869 | 3,025 | 3,128 | 3,401 | 3,929 | 4,254 | 4,469 | 4,657 |
| EBITDA 1 | 1,166 | 1,348 | 881.4 | 1,200 | 1,383 | 1,656 | 1,685 | 1,664 |
| EBIT 1 | 1,011 | 1,115 | 1,001 | 1,109 | 1,294 | 1,417 | 1,457 | 1,460 |
| Net income 1 | 646.6 | 647.5 | 647.2 | 347.3 | 444.5 | 923.1 | 937.8 | 939.9 |
| Net Debt 1 | 137.8 | -384.7 | -52.9 | -134.9 | -544.5 | -1,362 | -2,372 | -3,152 |
| Reference price 2 | 80.50 | 100.50 | 107.90 | 110.70 | 119.00 | 162.40 | 162.40 | 162.40 |
| Nbr of stocks (in thousands) | 82,243 | 82,380 | 82,599 | 82,700 | 82,100 | 82,100 | - | - |
| Announcement Date | 2/11/22 A | 2/9/23 A | 2/8/24 A | 2/13/25 A | 2/12/26 A | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 35.2x | 12.84x | 26.1x | 0.57% | 1,077B | ||
| 27.22x | 6.26x | 17.02x | 2.1% | 613B | ||
| 32.17x | 7.47x | 15.29x | 2.73% | 448B | ||
| 17.9x | 4.45x | 10.94x | 2.98% | 332B | ||
| 23.72x | 4.94x | 14x | 1.76% | 293B | ||
| 21.69x | 5.59x | 13.51x | 2.83% | 286B | ||
| 14.19x | 5.21x | 10.72x | 3.54% | 215B | ||
| 23.3x | 6.21x | 10.84x | 2.81% | 193B | ||
| -45.82x | 5.53x | 30.47x | 2.54% | 159B | ||
| Average | 16.62x | 6.50x | 16.54x | 2.43% | 401.79B | |
| Weighted average by Cap. | 24.44x | 7.95x | 18.32x | 1.97% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- IPN Stock
- I7G Stock
- Valuation Ipsen
Select your edition
All financial news and data tailored to specific country editions
















